A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
10/2011
10/20/2011	US20110257130 Compositions and Methods for Treatment of Renin-Angiotensin Aldosterone System (RAAS)- Related Disorders
10/20/2011	US20110257124 Esterified Polysaccharide Osmotics
10/20/2011	US20110257105 Synthetic peptide amides and dimers thereof
10/20/2011	US20110257097 Pharmaceutical compositions of somatotrophic hormones
10/20/2011	US20110257093 Therapies for acute renal failure
10/20/2011	US20110256151 Antibodies to human il-1beta
10/20/2011	US20110256149 Antibody formulation
10/20/2011	US20110256132 Myostatin binding proteins
10/20/2011	US20110256126 IL-17A/F Heterologous Polypeptides and Therapeutic Uses Thereof
10/20/2011	US20110256111 Isolated multipotent mesenchymal stem cell from human adult glomeruli (hgl-msc), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney
10/20/2011	US20110256110 Amniotic fluid cells and uses thereof
10/20/2011	US20110256093 Treating Disorders Associated with IL-20 Receptor-Mediated Signaling Pathway by Blocking IL-20 Receptor Activity
10/20/2011	US20110253133 Methods and compositions for administration of oxybutynin
10/19/2011	EP2377850A1 TRPV1 vanilloid receptor antagonists with a bicyclic portion
10/19/2011	EP2377548A2 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
10/19/2011	EP2376424A1 Highly pure cinacalcet or a pharmaceutically acceptable salt thereof
10/19/2011	EP2376104A1 Method for treating prostatitis utilizing modified pore-forming protein proaerolysin
10/19/2011	EP1957451B1 Soft anticholinergic zwitterions
10/19/2011	EP1948596B1 Soft anticholinergic esters
10/19/2011	EP1499613B1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/19/2011	EP1482931B1 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/19/2011	EP1372735B1 Conjugate of hydroxyalkyl starch and an active agent
10/19/2011	CN102224142A Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
10/19/2011	CN102223884A Solid pharmaceutical composition
10/19/2011	CN102220215A Health-care wine
10/19/2011	CN102218144A Method for regulating content of micro-ribonucleic acids in organism and use thereof
10/19/2011	CN102218132A Medicinal composition for treating nasal bleeding
10/19/2011	CN102218106A Traditional Chinese medicine composition for treating deficiency of liver and kidney and preparation method thereof
10/19/2011	CN102218085A Quality control method for leaves of lithocarpus litseifolius(Hance)Chun as medicinal material
10/19/2011	CN102218063A Method for preparing propiverine hydrochloride medicaments, and product and detection method thereof
10/19/2011	CN101954037B Chinese medicinal preparation for treating prostatitis
10/19/2011	CN101732660B Chinese medicinal preparation for treating prostate disease and preparation method thereof
10/19/2011	CN101647843B Chinese medicinal composition for treating prostatitis or prostate hyperplasia and preparation method
10/18/2011	US8039482 Composition of solifenacin or salt thereof for use in solid formulation
10/18/2011	CA2598294C Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative
10/18/2011	CA2551167C Aminoalcohol derivatives
10/18/2011	CA2478813C Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/18/2011	CA2475312C N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
10/18/2011	CA2470643C Cleavable reagents for specific delivery to disease sites
10/18/2011	CA2440644C Inhibitors of integrin .alpha.v.beta.6
10/18/2011	CA2434927C Pharmaceutical compositions with antibiotic activity
10/18/2011	CA2398018C Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/13/2011	WO2011125838A1 Therapeutic agent or preventive agent for urine collection disorder
10/13/2011	WO2011072216A9 Treatment methods utilizing stem cell mobilizers and immunosuppressive agents
10/13/2011	US20110251286 Crystalline salts and/or co-crystals of O-desmethyltramadol
10/13/2011	US20110251282 Liquid compositions of calcium acetate
10/13/2011	US20110251260 NOVEL siRNAS AND METHODS OF USE THEREOF
10/13/2011	US20110251238 Ppar agonist compositions and methods of use
10/13/2011	US20110251226 Cyclohexylamin isoquinolone derivatives
10/13/2011	US20110251220 Pharmaceutical compositions comprising gamma secretase modulators
10/13/2011	US20110251219 Treatment for glomerulonephritis with 2-[4-(7-ethyl-5h-pyrrolo[2,3-b]pyrazin-6-yl)phenyl]propan-2-ol
10/13/2011	US20110251217 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
10/13/2011	US20110251203 Use of pkc inhibitors in diabetic complications
10/13/2011	US20110251153 Prophylactic or therapeutic composition for hemoglobinuria or myoglobinuria
10/13/2011	US20110251123 Oral pharmaceutical composition of desmopressin
10/13/2011	US20110250261 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
10/13/2011	US20110250142 Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
10/13/2011	US20110250139 Modified Pyrazine Derivatives and Uses Thereof
10/13/2011	CA2793730A1 Therapeutic agent or preventive agent for urine collection disorder
10/12/2011	EP2374876A2 Therapy for alpha-galactosidase a deficiency
10/12/2011	EP2374796A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders
10/12/2011	EP2374454A1 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/12/2011	EP2374452A1 Nutrient composition
10/12/2011	EP2373316A1 Treatment for glomerulonephritis with 2 - ý 4- ( -7-ethyl-5h-pyrrolo ý 2,3-b¨-pyrazin- 6 -yl) propan-2-ol
10/12/2011	EP2373311A1 Inhibitors of hif-1 protein accumulation
10/12/2011	EP2373302A1 The use of compounds to inhibit 5a-reductase enzyme activity, and pharmaceutical and cosmetic compositions containing them
10/12/2011	EP1853266B1 2s,4r ketoconazole for treating diabetes, metabolic syndrome and other conditions
10/12/2011	EP1538888B1 Upper hitch link
10/12/2011	CN102216329A Treatment of interstitial cystitis
10/12/2011	CN102216326A Compositions and methods of use for thrombomodulin variants
10/12/2011	CN102216316A Substituted amine derivative and medicinal composition comprising same as the active ingredient
10/12/2011	CN102212449A Fagopyrum tataricm gaertn bud health-care wine
10/12/2011	CN102212446A Physical strength strengthening health-care medicinal liquor capable of tonifying kidney, strengthening yang and enhancing immunity and preparation method thereof
10/12/2011	CN102212437A Method for brewing medlar kidney-tonifying wine
10/12/2011	CN102212008A Tanshinol ligustrazine derivative and preparation method and application thereof
10/12/2011	CN102210814A Chinese medicinal composition for treating chronic prostatitis and preparation method thereof
10/12/2011	CN102210787A Application of philippine violet herb total phenol extract to treatment of hyperuricemia
10/12/2011	CN102210781A Preparation method and quality control method of traditional Chinese medicine Danmo capsule
10/12/2011	CN102210780A Traditional Chinese medicine for treating chronic nephritis
10/12/2011	CN102210769A Chinese medicinal composition for treating prostatitis
10/12/2011	CN102210768A Traditional Chinese medicine for treating prostatic cancer
10/12/2011	CN102210753A Traditional Chinese medicine composition for treating lithiasis in urinary system
10/12/2011	CN102210751A Medicinal composition for treating nephritides
10/12/2011	CN102210682A Application of tetrahydropyrimidine and derivatives thereof in preparing medicament for treating cystitis
10/12/2011	CN102210648A High-concentration furacilin micro emulsion washing fluid and preparation method and use thereof
10/12/2011	CN101773512B 8-amino acid/11-vitamin containing micro granule capsule and preparation method thereof
10/12/2011	CN101559154B Medicament for treating chronic prostatitis, and preparation method thereof
10/12/2011	CN101317912B Orally taken traditional Chinese medicine for treating chronic gonorrhea
10/12/2011	CN101199847B Drug compound for AT1 receptor antagonist/diuretic/folate coupling and uses thereof
10/11/2011	US8034799 Preventing and/or treating cardiovascular disease and/or associated heart failure
10/11/2011	US8034379 Hydrophilic gel foaming matrix; cellulose ethers
10/11/2011	US8034360 Use of human prostate cell lines in cancer treatment
10/11/2011	CA2488934C Aryl oxime derivatives as phosphodiesterase iv inhibitors for the treatment of diseases
10/11/2011	CA2472479C Deazapurines and uses thereof
10/11/2011	CA2468258C Peptide agonists of prostate-specific antigen, and uses therefor
10/11/2011	CA2400482C Bupropion metabolites and methods of their synthesis and use
10/11/2011	CA2394862C Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder
10/06/2011	WO2011123836A2 Pharmaceutical formulations for the treatment of overactive bladder
10/06/2011	WO2011123826A2 Prevention and treatment of cast nephropathy
10/06/2011	WO2011123027A1 Improved treatment of renal cell carcinoma

1 ... 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 ... 562